文献速递神经PETCT

双时相FDG PET/CT在脑肿瘤诊断与随访中的作用

The Role of Dual-Phase FDG PET/CT in the Diagnosis and Follow-Up of Brain Tumors.
PubMed 文献 · AJR Am J Roentgenol · 2020-08-25

回顾性评估32例患者51个恶性脑肿瘤的双时相FDG PET/CT,在注射FDG后30分钟(时间1)和3小时(时间2)采集。延迟显像提高了观察者间定性诊断准确性和一致性;早期与延迟定量参数的敏感度、特异度及准确率均较高。

要点

  • 延迟显像(3小时)可提高脑肿瘤定性诊断的观察者间一致性(时间1 κ=0.51 vs 时间2 κ=0.83)。
  • 病灶SUVmax阈值:时间1为7.20(敏感度89.2%、特异度85.7%),时间2为7.80(敏感度97.3%、特异度71.4%)。
  • 病灶与对侧白质SUVmax比值阈值:时间1为2.05(敏感度78.4%、特异度92.9%),时间2为2.36(敏感度81.1%、特异度85.7%)。

核心结论

  • 双时相FDG PET/CT可提高恶性脑肿瘤的病灶检出和诊断准确性。

研究设计与样本

  • 回顾性研究,纳入32例患者的51个恶性脑肿瘤。
  • 注射10 mCi(370 MBq)FDG后30分钟(时间1)和3小时(时间2)采集,空腹6小时。
  • 两名观察者独立定性评估,以加权Cohen kappa计算观察者间信度和准确性。
  • 病灶转归由病理结果(15个病灶)、系列MRI病灶稳定(代表非存活肿瘤)或新治疗后系列MRI病灶缩小(代表存活肿瘤)确定。

关键影像表现/征象

  • 存活病灶37个,非存活病灶14个。
  • 定性诊断准确性:第一观察者κ=0.45至κ=0.59,第二观察者κ=0.41至κ=0.66,延迟显像均提高。
  • 观察者间信度:时间1 κ=0.51,时间2 κ=0.83。

诊断标准与关键数值

  • 病灶SUVmax时间1阈值7.20,敏感度89.2%、特异度85.7%;时间2阈值7.80,敏感度97.3%、特异度71.4%。
  • 病灶/对侧白质SUVmax比值时间1阈值2.05,敏感度78.4%、特异度92.9%;时间2阈值2.36,敏感度81.1%、特异度85.7%。
  • 早期与延迟双时相FDG PET/CT的AUC及ROC分析显示敏感度、特异度和准确率表现相当。

临床应用与阅片要点

  • 延迟显像可提高脑肿瘤定性诊断的观察者间一致性。
  • 定量参数(病灶SUVmax及病灶/对侧白质SUVmax比值)的阈值可用于鉴别存活与非存活肿瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. FDG PET/CT of brain tumors is limited by background activity. Dual-phase FDG PET/CT can eliminate this limitation and allow discernment of viable tumors. Our aim was to assess the diagnostic capability of dual-phase FDG PET/CT qualitatively and quantitatively and to determine cutoff values for dual-phase FDG PET/CT in brain tumor imaging. MATERIALS AND METHODS. Retrospectively, 51 malignant brain tumors were evaluated with dual-phase FDG PET/CT in 32 patients. Acquisitions were performed 30 minutes (time 1) and 3 hours (time 2) after administration of 10 mCi (370 MBq) FDG and 6 hours of fasting. Two observers independently and qualitatively evaluated lesions. A weighted Cohen kappa was used to calculate interrater reliability and accuracy. Quantitatively, maximum standardized uptake value (SUVmax) was measured in the lesions, contralateral white matter (CWM), contralateral caudate nucleus head, and ipsilateral cerebellar cortex (CC). Lesion-to-CWM SUVmax, lesion-to-contralateral caudate nucleus head SUVmax, and lesion-to-ipsilateral CC SUVmax ratios at time 1 and time 2 were calculated. ROC analysis was used to determine optimum cutoff values, and AUC ratios were compared among quantitative parameters. Lesion outcome was determined by pathologic results (available in 15 lesions), lesion stability on serial MRI examinations (representing nonviable tumor), or decreased tumor size on serial MRI examinations after new treatment (representing viable tumor). RESULTS. Thirty-seven viable and 14 nonviable lesions were evaluated. Qualitatively, the diagnostic accuracy (first observer: κ = 0.45 to κ = 0.59; second observer: κ = 0.41 to κ = 0.66) and interrater reliability (at time 1: κ = 0.51; at time 2: κ = 0.83) improved with delayed imaging. AUC and ROC analysis showed comparably high sensitivity, specificity, and accuracy profiles for early and delayed dual-phase FDG PET/CT. Some of the proposed cutoff values were as follows: lesion SUVmax at time 1, 7.20 (sensitivity, 89.2%; specificity, 85.7%); lesion SUVmax at time 2, 7.80 (sensitivity, 97.3%; specificity, 71.4%); lesion-to-CWM SUVmax at time 1, 2.05 (sensitivity, 78.4%; specificity, 92.9%); and lesion-to-CWM SUVmax at time 2, 2.36 (sensitivity, 81.1%; specificity, 85.7%). CONCLUSION. Dual-phase FDG PET/CT improves lesion detection and diagnostic accuracy in malignant brain tumors.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Özütemiz C, Neil EC, Tanwar M, et al. The Role of Dual-Phase FDG PET/CT in the Diagnosis and Follow-Up of Brain Tumors. AJR Am J Roentgenol. 2020. PMID: 32841063. doi:10.2214/AJR.19.22571

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。